Why the study?
The mechanism of action of angiotensin-receptor neprilysin-inhibitors remains elusive despite broad clinical applications, and basic knowledge on heart failure-related pathophysiological alterations of the neprilysin system was lacking.
Key points are not available for this paper at this time.
Population
Translational porcine model of chronic heart failure
Design
Animal translational study
Answers are grounded in this paper and cite their sources.
Should not alter plasma NEP biomarker use in HF practice; leaves open kidney's systemic role for human validation.
Based on the investigation of neprilysin (NEP) regulation in a translational porcine model of chronic heart failure (HF), this study concluded: 1) that kidneys might play a crucial part in systemic NEP regulation based on 20 to 100 higher NEP content and/or activity compared with any other organ; 2) NEP seems to be downregulated under HF conditions; and 3) that the value of plasma NEP concentrations and activity as biomarkers is questionable. For the first time, these data provide basic knowledge on HF-related pathophysiological alterations of the NEP system and contribute to understanding the mechanism of action of angiotensin-receptor neprilysin-inhibitors, which remains elusive despite broad clinical applications.
No takes yet. Share an insight, caveat, or question.
Pávó et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: